Influence of Combination Therapy with Dulaglutide or Liraglutide and SGLT2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Post-hoc Analysis of the RECAP Study.

Dulaglutide and liraglutide may have different effects on albuminuria and the kidney function in combination with SGLT2i.

Authors

Shunichiro Tsukamoto (ORCID: https://orcid.org/0000-0003-1146-6810)
Kei Takeshita (ORCID: https://orcid.org/0000-0001-7610-498X)
Takuya Hashimoto (ORCID: https://orcid.org/0000-0002-7690-1046)
Yoshimi Muta
Kazuo Kobayashi (ORCID: https://orcid.org/0000-0002-1284-9728)
Daisuke Tsuriya (ORCID: https://orcid.org/0009-0001-7891-5046)
Masao Toyoda (ORCID: https://orcid.org/0000-0003-4142-1218)
Moritsugu Kimura (ORCID: https://orcid.org/0000-0001-8789-6425)
Keizo Kanasaki (ORCID: https://orcid.org/0000-0002-9563-502X)
Kouichi Tamura (ORCID: https://orcid.org/0000-0002-0660-5372)
Yuichi Takashi (ORCID: https://orcid.org/0000-0002-3728-1139)
Hisashi Yokomizo (ORCID: https://orcid.org/0000-0001-7759-2014)
Daiji Kawanami (ORCID: https://orcid.org/0000-0002-8926-4701)